Endocrine and Neuroendocrine Cancers / / Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors.
Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | [Place of publication not identified] : : MDPI - Multidisciplinary Digital Publishing Institute,, 2023. |
Year of Publication: | 2023 |
Language: | English |
Physical Description: | 1 online resource (198 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993580983504498 |
---|---|
ctrlnum |
(CKB)5680000000300105 (NjHacI)995680000000300105 (EXLCZ)995680000000300105 |
collection |
bib_alma |
record_format |
marc |
spelling |
Endocrine and Neuroendocrine Cancers / Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors. [Place of publication not identified] : MDPI - Multidisciplinary Digital Publishing Institute, 2023. 1 online resource (198 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives. In English. Preface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177. Neuroendocrine tumors. Neuroendocrinology. 3-0365-5763-6 Fazio, Nicola, editor. Amoroso, Vito, editor. Berruti, Alfredo, editor. |
language |
English |
format |
eBook |
author2 |
Fazio, Nicola, Amoroso, Vito, Berruti, Alfredo, |
author_facet |
Fazio, Nicola, Amoroso, Vito, Berruti, Alfredo, |
author2_variant |
n f nf v a va a b ab |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
title |
Endocrine and Neuroendocrine Cancers / |
spellingShingle |
Endocrine and Neuroendocrine Cancers / Preface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177. |
title_full |
Endocrine and Neuroendocrine Cancers / Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors. |
title_fullStr |
Endocrine and Neuroendocrine Cancers / Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors. |
title_full_unstemmed |
Endocrine and Neuroendocrine Cancers / Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors. |
title_auth |
Endocrine and Neuroendocrine Cancers / |
title_new |
Endocrine and Neuroendocrine Cancers / |
title_sort |
endocrine and neuroendocrine cancers / |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute, |
publishDate |
2023 |
physical |
1 online resource (198 pages) |
contents |
Preface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177. |
isbn |
3-0365-5764-4 3-0365-5763-6 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC280 |
callnumber-sort |
RC 3280 E55 E536 42023 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.9944 |
dewey-sort |
3616.9944 |
dewey-raw |
616.9944 |
dewey-search |
616.9944 |
work_keys_str_mv |
AT fazionicola endocrineandneuroendocrinecancers AT amorosovito endocrineandneuroendocrinecancers AT berrutialfredo endocrineandneuroendocrinecancers |
status_str |
n |
ids_txt_mv |
(CKB)5680000000300105 (NjHacI)995680000000300105 (EXLCZ)995680000000300105 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Endocrine and Neuroendocrine Cancers / |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1796652748088803328 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03250nam a2200349 i 4500</leader><controlfield tag="001">993580983504498</controlfield><controlfield tag="005">20230324055403.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230324s2023 xx o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-0365-5764-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5680000000300105</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995680000000300105</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995680000000300105</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.E55</subfield><subfield code="b">.E536 2023</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.9944</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Endocrine and Neuroendocrine Cancers /</subfield><subfield code="c">Alfredo Berruti, Vito Amoroso, Nicola Fazio, editors.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (198 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Endocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Preface to "Endocrine and Neuroendocrine Cancers" vii -- Endocrine and Neuroendocrine Tumors: A Special Issue 1 -- Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes 5 -- Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise 19 -- Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy 39 -- Molecular Profiling o f Well-Differentiated N euroendocrine T umours: T he R ole o f c tDNA in Real-World Practice 53 -- Predictive and Prognostic Role of Pre-Therapy and Interim 68Ga-DOTATOC PET/CT Parameters in Metastatic Advanced Neuroendocrine Tumor Patients Treated with PRRT 63 -- Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia 75 -- Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 89 -- Anaplastic Thyroid Carcinoma: An Update 103 -- Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency 129 -- Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? 143 -- Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials 159 -- Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A -- Systematic Review 177.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Neuroendocrine tumors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Neuroendocrinology.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-5763-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fazio, Nicola,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Amoroso, Vito,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berruti, Alfredo,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 12:27:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2023-02-11 21:29:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343013600004498&Force_direct=true</subfield><subfield code="Z">5343013600004498</subfield><subfield code="b">Available</subfield><subfield code="8">5343013600004498</subfield></datafield></record></collection> |